BioCentury
ARTICLE | Clinical News

Synagis palivizumab: Marketed

November 8, 1999 8:00 AM UTC

MEDI reported data from 2 surveys evaluating Synagis' efficacy during the 1998/1999 RSV season. A survey of 1,839 patients showed a 2.3 percent RSV hospitalization rate for Synagis-treated patients co...